Merck & Co Inc
NYSE: MRK
$97.11
-$1.25 (-1.3%)
Real Time Data Delayed 15 Min.
MRK Articles
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
Published:
Ebola fears have subsided and the development of a vaccine or related drugs has been put on the back burner for most, but one biotech made waves in the market Monday morning.
Published:
thinkstockJuly 29, 2015: Markets opened higher on Wednesday and two of the three major indexes spend all day trading above the break-even line; only the Nasdaq Composite took a brief visit into the...
Published:
Last Updated:
ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis C vaccines (HCV) Harvoni and Solvaldi. For the most part the resulting...
Published:
Last Updated:
ThinkstockMerck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday before the markets opened. The pharmaceutical giant had $0.86 in earnings per share (EPS) on $9.8...
Published:
Last Updated:
ThinkstockMerck & Co. Inc. (NYSE: MRK) reports on Tuesday morning comes into earnings with shares up only 2.7% or so year to date, and up only about 1.7% from a year ago. Thomson Reuters has...
Published:
Last Updated:
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market...
Published:
Last Updated:
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc....
Published:
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
Published:
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all could help cushion a portfolio...
Published:
thinkstockJune 26, 2015: Markets opened higher on Friday but tech stocks almost immediately dragged down the Nasdaq Composite and eventually weighed on the S&P 500 index as well. A weak report...
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Published:
thinkstockJune 22, 2015: Markets opened higher on Monday as investors appeared optimistic that Greece and the European Central Bank would strike a deal. That hasn’t happened yet today. Gold dropped...
Published:
Last Updated:
thinkstockJune 12, 2015: Markets opened lower on Friday as a solution to the Greek-European Union seems to draw further away from negotiators. Energy and healthcare stocks both opened weak and were...
Published:
Last Updated:
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Published: